Monrab IT 20mg/150mg Tablet is a fixed-dose combination medication containing rabeprazole sodium 20mg and itopride hydrochloride 150mg. This tablet is indicated for the treatment of gastroesophageal reflux disease (GERD) and erosive esophagitis, as well as for the prevention of recurrent duodenal ulcers. Rabeprazole, a proton pump inhibitor, selectively inhibits the final common pathway of gastric acid secretion, thereby reducing acid production and symptom relief. Itopride, a dopamine antagonist, enhances gastric motility and reduces acid reflux by antagonizing the inhibitory effect of dopamine on gastric contraction. The combination of these two agents offers a comprehensive approach to treating GERD and related conditions. The tablet is available in a convenient once-daily dosing regimen, making it a practical and effective treatment option for patients seeking relief from symptoms of acid reflux and heartburn.